Mammaprint TIME’s November 30, 2007Posted by ramunas in breast cancer, cancer genetics, genetic testing, MammaPrint.
“With MammaPrint, a genetic test of a tumor’s DNA, patients and doctors can get a better handle on how likely it is that the cancer will spread”
It’s also the first microarray test approved by the FDA.
As you may noticed, there are several guys (aka doctors) on the corporate page design. Accidentally, when I was browsing our local website about COPD, I was surprised to find the same “template-doctors” there 🙂